Shopping Cart 0
Cart Subtotal
USD 0

Salk Institute for Biological Studies - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute's areas of research comprise aging and regenerative medicine, cancer biology, immune system biology, metabolism and diabetes, neuroscience and neurological disorders, and plant biology. Its research provides development of new therapies and treatments for diseases such as cancer, AIDS, Alzheimer's disease, cardiovascular disorders, anomalies of brain, birth defects, diabetes and metabolism, gene therapy, plant biology, vision, and williams syndrome, among others. Salk offers education outreach programs that deliver research impact on human health. The institute operates research centers such as Salk Cancer Center, Crick-Jacobs Center, Helmsley Center for Genomic Medicine, Center for the Neurobiology of Vision and Center for Nutritional Genomics, among others. Salk is headquartered in San Diego, California, the US.

Salk Institute for Biological Studies-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Salk Institute Enters into Agreement with Indivumed 10

Ipsen Extends Research Agreement with Salk Institute for Biological Studies 11

Licensing Agreements 12

Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 12

StemCell Technologies Enters into Licensing Agreement with Salk Institute for BrainPhys 13

Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 14

Salk Institute for Biological Studies-Key Competitors 15

Salk Institute for Biological Studies-Key Employees 16

Salk Institute for Biological Studies-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Government and Public Interest 18

Oct 02, 2018: Salk's Janelle Ayres receives nih pioneer award for novel approaches to infectious disease 18

Sep 20, 2018: Decoding the structure of an RNA-based CRISPR system 19

Sep 18, 2018: Tweaking cells' gatekeepers could lead to new way to fight cancer 20

Sep 13, 2018: Research in yeast leads to serendipitous finding about a central nervous system disorder 21

Sep 05, 2018: The alchemy of healing: Researchers turn open wounds into skin 22

Aug 30, 2018: A master switch controls aggressive breast cancer 23

Aug 23, 2018: Salk's donors give USD 48.5 million to support scientific innovation in FY18 25

Aug 21, 2018: Salk Institute receives USD 2 million for cancer research initiative 26

Jul 11, 2018: Janelle Ayres receives USD 1 million from W. M. Keck Foundation for infectious disease research 27

Jun 26, 2018: Salk researchers win five competitive grants for cancer research 28

May 18, 2018: Salk Institute receives USD 1.5 million for Alzheimer's research from NANOS 30

Mar 14, 2018: CRISPR genetic editing takes another big step forward, targeting RNA 31

Mar 13, 2018: Molecule That Gives Energy-Burning Brown Fat Its Identity Could Lead To Drugs For Obesity 33

Sep 19, 2017: CPRIT awards USD 34M to UTSW for cancer research recruitment 34

May 30, 2017: Brain's immune cells linked to Alzheimer's, Parkinson's, schizophrenia 36

Feb 14, 2017: Salk scientist awarded inaugural Sjoberg Prize for cancer breakthrough 38

Other Significant Developments 39

Oct 18, 2018: Brain cells called astrocytes have unexpected role in brain plasticity 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Key Facts 2

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Salk Institute for Biological Studies, Deals By Therapy Area, 2012 to YTD 2018 8

Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Salk Institute Enters into Agreement with Indivumed 10

Ipsen Extends Research Agreement with Salk Institute for Biological Studies 11

Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 12

StemCell Technologies Enters into Licensing Agreement with Salk Institute for BrainPhys 13

Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 14

Salk Institute for Biological Studies, Key Competitors 15

Salk Institute for Biological Studies, Key Employees 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Salk Institute for Biological Studies, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.